Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - HELIUS MEDICAL TECHNOLOGIES, INC. | hsdt-ex322_7.htm |
| EX-31.2 - EX-31.2 - HELIUS MEDICAL TECHNOLOGIES, INC. | hsdt-ex312_9.htm |
| EX-31.1 - EX-31.1 - HELIUS MEDICAL TECHNOLOGIES, INC. | hsdt-ex311_10.htm |
| 10-Q - 10-Q - HELIUS MEDICAL TECHNOLOGIES, INC. | hsdt-10q_20200331.htm |
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
HELIUS MEDICAL TECHNOLOGIES, INC.
FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2020
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I am the Chief Executive Officer of Helius Medical Technologies, Inc., a Delaware corporation (the “Company”). I am delivering this certificate in connection with the Form 10-Q of the Company for the quarter ended March 31, 2020 and filed with the Securities and Exchange Commission (“Form 10-Q”).
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my knowledge, the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: May 11, 2020 |
|
/s/ Phillippe Deschamps |
|
|
|
Phillippe Deschamps |
|
|
|
Chief Executive Officer and Director |
|
|
|
(Principal Executive Officer) |